Pacira | PCRX - Trade Creditors


Pacira reported $14.01M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Assertio Holdings USD 14.66M 3.81M Sep/2025
Astellas Pharma JPY 199.75B 17.8B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Heron Therapeutics USD 8.97M 24K Mar/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novo Nordisk DKK 14.8B 4.96B Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026
Xoma USD 2.65M 1.52M Sep/2025
Zoetis USD 507M 20M Mar/2026